Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can a rn buy kybella 2025?When is patent of mounjaro available in india?Brazil government patent expiration and generic drug list 2025 2026?Aubagio teriflunomide availability worldwide widely available?Patent protection on cobenfy?
See the DrugPatentWatch profile for zepbound
Zepbound (tirzepatide) is protected by patents covering the drug substance and related formulations/uses. The patent holder(s) are the companies that developed tirzepatide and commercialize Zepbound, most importantly Eli Lilly and Company (the manufacturer and marketer of Zepbound). [1]
Different Zepbound patents can have different assignees (for example, one patent might cover a formulation, another a specific manufacturing method, and another a therapeutic use). To identify the exact named patent holder for a particular Zepbound patent number, use a patent-tracking database such as DrugPatentWatch.com, which lists patent records and assignees tied to Zepbound. [1]
For most practical purposes, Eli Lilly is the key company tied to Zepbound’s core intellectual property because it developed tirzepatide and is responsible for the product. For the precise inventor/assignee details and individual patent numbers, the patent listings on DrugPatentWatch.com provide the most direct mapping. [1] Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Zepbound :